Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo L Gaffo

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Annals of Internal Medicine|June 6, 2022
In knee OA, PT vs. glucocorticoid injections had an incremental cost-effectiveness ratio of $35 527/QALY gainedAngelo L Gaffo
Best Practice & Research. Clinical Rheumatology|March 20, 2013
Thrombosis in vasculitisAngelo L Gaffo
JAMA|February 6, 2024
Serum Urate and Its Association With Gout FlaresAngelo L Gaffo
Rheumatic Diseases Clinics of North America|August 7, 2010
Diagnostic approach to ANCA-associated vasculitidesAngelo L Gaffo
Current Opinion in Rheumatology|May 2, 2024
Investigating gout flares: beyond a definitionCharles Sutherland, Angelo L Gaffo
Nature Clinical Practice. Rheumatology|December 3, 2008
Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares?Angelo L Gaffo, Kenneth G Saag
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 30, 2011
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?Angelo L Gaffo, Kenneth G Saag
Current Rheumatology Reports|February 4, 2017
Rituximab in ANCA-Associated VasculitisRomina I Hassan, Angelo L Gaffo
The Lancet. Rheumatology|January 31, 2024
Self-management of gout using a mobile appLisa K Stamp, Angelo L Gaffo
Annals of Internal Medicine|January 15, 2019
Web Exclusive. Annals On Call - Understanding Gout PathophysiologyRobert M Centor, Angelo L Gaffo
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Annals of Internal Medicine|June 6, 2022
In knee OA, PT vs. glucocorticoid injections had an incremental cost-effectiveness ratio of $35 527/QALY gainedAngelo L Gaffo
Best Practice & Research. Clinical Rheumatology|March 20, 2013
Thrombosis in vasculitisAngelo L Gaffo
JAMA|February 6, 2024
Serum Urate and Its Association With Gout FlaresAngelo L Gaffo
Rheumatic Diseases Clinics of North America|August 7, 2010
Diagnostic approach to ANCA-associated vasculitidesAngelo L Gaffo
Current Opinion in Rheumatology|May 2, 2024
Investigating gout flares: beyond a definitionCharles Sutherland, Angelo L Gaffo
Nature Clinical Practice. Rheumatology|December 3, 2008
Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares?Angelo L Gaffo, Kenneth G Saag
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 30, 2011
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?Angelo L Gaffo, Kenneth G Saag
Current Rheumatology Reports|February 4, 2017
Rituximab in ANCA-Associated VasculitisRomina I Hassan, Angelo L Gaffo
The Lancet. Rheumatology|January 31, 2024
Self-management of gout using a mobile appLisa K Stamp, Angelo L Gaffo
Annals of Internal Medicine|January 15, 2019
Web Exclusive. Annals On Call - Understanding Gout PathophysiologyRobert M Centor, Angelo L Gaffo
Pageof 6